BinaxNOWTM

COVID-19 Ag CARD HOME TEST KIT

PROCEDURE CARD

DO NOT OPEN ITEMS UNTIL INSTRUCTED TO DO SO
BinaxNOW COVID-19 Ag CARD HOME TEST KIT

The BinaxNOWTM COVID-19 Ag Card Home Test is for 

FDA Emergency Use Authorization (EUA) Only

For In Vitro Diagnostic (IVD) Use

HOW TO USE THIS TEST

Serial testing should be performed in all individuals with negative 

results; individuals with symptoms of COVID-19 and initial 

negative results should be tested again after 48 hours. Individuals 

without symptoms of COVID-19, and with initial negative results, 

should be tested again after 48 hours and, if the 2nd test is also 

negative, a 3rd time after an additional 48 hours. You may need 

to purchase additional tests to perform this serial (repeat) testing. 

If you test negative but continue to have symptoms of 

COVID-19, and both your first and second tests are negative, 

you may not have COVID-19, however you should follow-up 

with your healthcare provider. 

If your test is positive, then proteins from the virus that causes 

COVID-19 have been found in your sample and you likely have 

COVID-19.

WARNINGS, PRECAUTIONS and SAFETY 

INFORMATION

1. Read all instructions carefully before performing the test. 

Failure to follow the instructions may result in inaccurate test 

results. 

2. For in vitro diagnostic use.

3. In the USA, this product has not been FDA cleared or approved 

but has been authorized by FDA under an Emergency Use 

Authorization. This product has been authorized only for the 

detection of proteins from SARS-CoV-2, not for any other 

viruses or pathogens. The emergency use of this product is only 

authorized for the duration of the declaration that circumstances 

exist justifying the authorization of emergency use of in vitro

diagnostics for detection and/or diagnosis of COVID-19 under 

Section 564(b)(1) of the Federal Food, Drug, and Cosmetic 

Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is 

terminated or authorization is revoked sooner.

4. Wear safety mask or other face covering when collecting 

anterior nares swab specimen from a child or another 

individual. 

5. Use of gloves is recommended when conducting testing. 

6. Keep testing kit and kit components out of the reach of 

children and pets before and after use.

7. Incorrect test results may occur if a specimen is incorrectly 

collected or handled.

8. Leave test card sealed in its foil pouch until just before use. 

9. Do not use if any of the test kit contents or packaging is 

damaged. 
BinaxNOW COVID-19 Ag CARD HOME TEST KIT

The BinaxNOWTM COVID-19 Ag Card Home Test is for 

FDA Emergency Use Authorization (EUA) Only

10. Once opened, the test card should be used immediately.

11. Do not dip the swab into the liquid reagent or other liquid 

before inserting the swab into the nose. 

12. Do not touch swab tip when handling the swab sample.

13. Do not use kit past its expiration date.

14. Do not mix components from different kit lots.

15. All kit components are single use items. Do not use with 

multiple specimens. Do not reuse the used test card or swab.

16. Wash hands thoroughly or use hand sanitizer after handling.

17. Dispose of kit components and patient samples in household 

trash.

18. INVALID RESULTS can occur when an insufficient volume 

of extraction reagent is added to the test card. To ensure 

delivery of adequate volume, hold vial vertically, 1/2 inch 

above the swab well, and add drops slowly.

19. Serial testing should be performed in individuals with negative 

results at least twice over three days (with 48 hours between 

tests) for symptomatic individuals and three times over five 

days (with at least 48 hours between tests) for asymptomatic 

individuals. You may need to purchase additional tests to 

perform this serial (repeat) testing. 

20. An anterior nasal swab sample can be self-collected by an 

individual age 15 years and older. Children age 2 to 15 years 

should be tested by an adult.

21. Do not use on anyone under 2 years of age.

22. If you have had symptoms longer than 7 days you should 

consider testing at least three times over five days with at 

least 48 hours between tests.

23. Do not read test results before 15 minutes or after 30 minutes. 

Results read before 15 minutes or after 30 minutes may lead 

to a false positive, false negative, or invalid result.

24. The Reagent Solution contains a harmful chemical (see table 

below). Do not ingest any kit components. If the solution 

contacts the skin or eye, flush with copious amounts of water. 

If irritation persists, seek medical advice: www.poisonhelp.org 

or 1-800-222-1222.

Chemical Name/CAS GHS Code for each Ingredient Concentration

Sodium Azide/26628-22-8 Acute Tox. 2 (Oral), H300

Acute Tox. 1 (Dermal), H310

0.0125%

There is a higher chance of false negative results with antigen 

tests than with laboratory-based molecular tests. This means that 

there is a higher chance this test will give you a negative result 

when you have COVID-19.

For more information on EUAs please visit: https://www.fda.gov/

emergencypreparedness-and-response/mcm-legal-regulatoryand-policy-framework/emergencyuse-authorization.

For the most up to date information on COVID-19, please visit: 

www.cdc.gov/COVID19.
BinaxNOW COVID-19 Ag CARD HOME TEST KIT

Frequently Asked Questions

What are the known and potential risks and 

benefits of this test?

Potential risks include:

• Possible discomfort during sample collection.

• Possible incorrect test results (see Results section).

Potential benefits include:

• The results, along with other information, can help your healthcare 

provider make informed recommendations about your care.

• The results of this test may help limit the spread of 

COVID-19 to your family and others in your community.

For more information on EUAs go here: https://www.fda.gov/

emergencypreparedness-and-response/mcm-legal-regulatoryand-policy-framework/emergencyuse-authorization

What is the difference between an antigen and 

molecular test?

There are different kinds of tests for COVID-19. Molecular tests 

(also known as PCR tests) detect genetic material from the 

virus. Antigen tests, such as the BinaxNOW COVID-19 Ag Card 

Home Test, detect proteins from the virus. Due to the lower 

sensitivity of antigen tests, there is a higher chance this test will 

give you a false negative result when you have COVID-19 than a 

molecular test would. 

How Accurate is this Test?

Clinical studies have shown that antigen tests more accurately 

determine whether you are infected with the virus that causes 

COVID-19 when taken multiple times across several days. 

Repeat testing improves test accuracy. This serial testing 

approach is recommended to minimize the risk of incorrect 

results. For more information on the performance of the test 

and how the performance may apply to you, please refer to the 

performance data in the Healthcare Provider Instructions for Use 

available at www.globalpointofcare.eifu.abbott. 

What if I Have a Positive Test Result? 

A positive result means that it is very likely you have COVID-19 

because proteins from the virus that causes COVID-19 were 

found in your sample. You should self isolate from others and 

contact a healthcare provider for medical advice about your 

positive result. 

What if I have a Negative Test Result? 

A negative test result indicates that antigens from the virus that 

causes COVID-19 were not detected in your sample. However, if 

you have symptoms of COVID-19, and your first test is negative, 

you should test again in 48 hours since antigen tests are not 

as sensitive as molecular tests. If you do not have symptoms 
BinaxNOW COVID-19 Ag CARD HOME TEST KIT

Frequently Asked Questions

and received a negative result, you should test at least two 

more times with 48 hours in between tests for a total of three 

tests. If you have a negative result, it does not rule out SARSCoV-2 infection; you may still be infected and you may still 

infect others. It is important that you work with your healthcare 

provider to help you understand the next steps you should take. 

What does an Invalid Test Result mean? 

An invalid result means the test was not able to tell if you have 

COVID-19 or not. If the test is invalid, a new swab should be 

used to collect a new nasal specimen and you should test again 

with a new test. 

IMPORTANT 

Do not use this test as the only guide to manage your illness. 

Consult your healthcare provider if your symptoms persist 

or become more severe. Individuals should provide all results 

obtained with this product to their healthcare provider. 

LIMITATIONS 

The performance of this test was established based on the 

evaluation of a limited number of clinical specimens collected 

between January, 2021, and May, 2022. The clinical performance 

has not been established for all circulating variants but is 

anticipated to be reflective of the prevalent variants in circulation 

at the time and location of the clinical evaluation. Performance 

at the time of testing may vary depending on the variants 

circulating, including newly emerging strains of SARSCoV-2 and 

their prevalence, which change over time. 

All COVID-19 antigen test negative results are presumptive and 

confirmation with a molecular assay may be necessary. If you 

continue to have symptoms of COVID-19, and both your first 

and second tests are negative, you may not have COVID-19, 

however you should follow-up with a healthcare provider. 

If the test is positive, then proteins from the virus that causes 

COVID-19 have been found in the sample and you likely have 

COVID-19. 

There is a higher chance of false negative results with antigen 

tests than with laboratory-based molecular tests due to the 

sensitivity of the test technology. This means that there is a 

higher chance this test will give a false negative result in an 

individual with COVID-19 as compared to a molecular test, 

especially in samples with low viral load. 

Incorrect test results may occur if a specimen is incorrectly 

collected or handled. 

This test is read visually and has not been validated for use by 

those with impaired vision or color-impaired vision.
BinaxNOW COVID-19 Ag CARD HOME TEST KIT

Intended Use

The BinaxNOW COVID-19 Ag Card Home Test is a lateral flow 

immunoassay device intended for the qualitative detection of 

nucleocapsid protein antigen from SARS-CoV-2. This test is authorized 

for non-prescription home use with self-collected observed anterior 

nasal (nares) swab samples from individuals aged 15 years or older or 

adult collected anterior nasal (nares) swab samples from individuals aged 

2 years or older. This test is authorized for individuals with symptoms of 

COVID-19 within the first seven days of symptom onset when tested at 

least twice over three days with at least 48 hours between tests, and for 

individuals without symptoms or other epidemiological reasons to suspect 

COVID-19, when tested at least three times over five days with at least 

48 hours between tests. 

The BinaxNOW COVID-19 Ag Card Home Test is to be performed only 

with the supervision of a telehealth proctor.

The BinaxNOW COVID-19 Ag Card Home Test does not differentiate 

between SARS-CoV and SARS-CoV-2.

Results are for the identification of SARS-CoV-2 nucleocapsid protein 

antigen which is generally detectable in anterior nasal (nares) swabs 

during the acute phase of infection. Positive results indicate the presence 

of viral antigens, but clinical correlation with patient history and other 

diagnostic information is necessary to determine infection status. Positive 

results do not rule out bacterial infection or co-infection with other 

viruses. The agent detected may not be the definite cause of disease. 

Individuals who test positive with the BinaxNOW COVID-19 Ag Card 

Home Test should self-isolate and seek follow up care with their physician 

or healthcare provider as additional testing may be necessary.

All negative results are presumptive and confirmation with a molecular 

assay, if necessary, for patient management, may be performed. Negative 

results do not rule out SARS-CoV-2 infection and should not be used as 

the sole basis for treatment or patient management decisions, including 

infection control measures such as isolating from others and wearing 

masks. Negative results should be considered in the context of a patient’s 

recent exposures, history and the presence of clinical signs and symptoms 

consistent with COVID-19.

Individuals who test negative and continue to experience COVID-like 

symptoms of fever, cough and/or shortness of breath may still have 

SARS-CoV-2 infection and should seek follow up care from their 

healthcare provider. 

Individuals should provide all results obtained with this product to their 

healthcare provider for public health reporting and to receive appropriate 

medical care. All healthcare providers will report all test results they receive 

from individuals who use the authorized product to relevant public health 

authorities in accordance with local, state, and federal requirements using 

appropriate LOINC and SNOMED codes, as defined by the Laboratory 

In Vitro Diagnostics (LIVD) Test Code Mapping for SARS-CoV-2 Tests

provided by CDC.

The BinaxNOW COVID-19 Ag Card Home Test is intended for nonprescription self-use and/or, as applicable for an adult lay user testing 

another person aged 2 years or older in a non-laboratory setting. 

The BinaxNOW COVID-19 Ag Card Home Test is only for in vitro

diagnostic use under the Food and Drug Administration’s Emergency Use 

Authorization. This product has not been FDA cleared or approved.
BinaxNOW COVID-19 Ag CARD HOME TEST KIT

Wash Your Hands

Wash or sanitize your hands. Make sure they are dry before starting.
BinaxNOW COVID-19 Ag CARD HOME TEST KIT

1 Set Up

It is recommended gloves (not provided) also be used during testing. Your box may contain 

more than one test kit. Use only 1 of each of the following for each test:

! DO NOT open items until instructed.

Open your test kit. You should have:

1 Swab 1 Test Card 1 Bottle

BinaxNOWTM

COVID-19 Ag CARD

SAMPLE

CONTROL

or
BinaxNOW COVID-19 Ag CARD HOME TEST KIT

2 Open Pouch and Scan QR Code on Card

If using a mobile device: If using a computer:

BinaxNOWTM

COVID-19 Ag CARD

SAMPLE

CONTROL
BinaxNOW COVID-19 Ag CARD HOME TEST KIT

3 Open Card

! Card must stay FLAT on table for entire test.

Top Hole

Bottom Hole

Test Strip

Results Window

DO NOT 

touch any 

parts on 

inside of card.
BinaxNOW COVID-19 Ag CARD HOME TEST KIT

4 Apply Fluid to Top Hole

A. Remove dropper 

bottle cap.

B. Hold dropper bottle 

straight over TOP HOLE, 

not at an angle.

C. Put 6 DROPS into 

TOP HOLE. Do not 

touch card with tip.

6 drops

Note: False negative results 

may occur if less than 6 drops 

of fluid is used.
BinaxNOW COVID-19 Ag CARD HOME TEST KIT

5 Open Swab

! Keep fingers away from swab end.

A. Open swab package at 

stick end.

B. Take swab out.
BinaxNOW COVID-19 Ag CARD HOME TEST KIT

6 Swab Left Nostril

A. Insert the entire absorbent tip 

of the swab (usually 1/2 to 3/4 of 

an inch) into left nostril.

Up to 3/4 of 

an inch.

B. Firmly brush against insides of

nostril in a circular motion 5 times

or more for at least 15 seconds.

x5
BinaxNOW COVID-19 Ag CARD HOME TEST KIT

7 Swab Right Nostril

A. Remove swab and insert it 

into right nostril.

B. Firmly brush against insides of 

nostril in a circular motion 5 times 

or more for at least 15 seconds.

x5

Note: False negative results may occur if the nasal swab is not 

properly collected.
BinaxNOW COVID-19 Ag CARD HOME TEST KIT

8 Insert Swab into Bottom Hole

! Keep card FLAT on table.

Insert swab tip into BOTTOM HOLE and firmly push up until tip

fills TOP HOLE.
BinaxNOW COVID-19 Ag CARD HOME TEST KIT

9 Turn Swab 3 Times

! Keep card FLAT on table.

Turn swab to right 3 times in card and leave it in place.

Note: False negative results can x3

occur if the sample swab is not 

turned prior to closing the card.
BinaxNOW COVID-19 Ag CARD HOME TEST KIT

10 Peel Strip

! DO NOT remove swab. ! Keep card FLAT on table.

Keep swab in place. Peel adhesive liner off.
BinaxNOW COVID-19 Ag CARD HOME TEST KIT

11 Close Card and Seal

! DO NOT remove swab. ! Keep card FLAT on table.

Close left side of card over swab to seal it. Keep card face up on table.
BinaxNOW COVID-19 Ag CARD HOME TEST KIT

12 Wait 15 Minutes

! DO NOT disturb card during this time.

15:00

Note: False results can occur 

if the card is disturbed/moved 

or test results are read before 

15 minutes. 
BinaxNOW COVID-19 Ag CARD HOME TEST KIT

13 Scan QR Code

If using a mobile device: If using a computer:

BinaxNOWTM

COVID-19 Ag CARD

SAMPLE

CONTROL
BinaxNOW COVID-19 Ag CARD HOME TEST KIT

14 Show Result to Your Proctor

BinaxNOWTM

COVID-19 Ag CARD

SAMPLE

CONTROL

SAMPLE

CONTROL
BinaxNOW COVID-19 Ag CARD HOME TEST KIT

15 Steps to Check Your Results

There are three types of results possible. You will be instructed how to

read each type in a specific order. Follow this order with your proctor:

1. Check for a Positive Result

2. Check for a Negative Result

3. Check for an Invalid Result

Repeat testing is needed to improve test accuracy. 

Please follow the table below when interpreting test 

results for COVID-19.

Status on First 

Day of Testing

First Result 

Day 1

Second Result 

Day 3

Third Result 

Day 5 Interpretation

With 

Symptoms

Positive N/A N/A Positive for COVID-19

Negative Positive N/A Positive for COVID-19

Negative Negative N/A Negative for COVID-19

Without 

Symptoms

Positive N/A N/A Positive for COVID-19

Negative Positive N/A Positive for COVID-19

Negative Negative Positive Positive for COVID-19

Negative Negative Negative Negative for COVID-19

Results should be considered in the context of 

an individual’s recent exposures, history, and the 

presence of clinical signs and symptoms consistent 

with COVID-19.
BinaxNOW COVID-19 Ag CARD HOME TEST KIT

16 Check for Positive COVID-19 Result

Find result window and look carefully for two pink/purple lines in window.

•Positive Result: Two pink/purple lines will appear. One on the top half 

and one on the bottom half. COVID-19 was detected. 

You do not need to perform repeat testing if you have a positive result at any time.

Positive Positive

Solid Line Faint Line

OR

CONTROL

SAMPLE Look very closely!

The bottom line can be very faint.

Any pink/purple line visible here 

indicates a positive result.

Here are photos of actual positive tests. On the right, note how faint the bottom line can get.
BinaxNOW COVID-19 Ag CARD HOME TEST KIT

Positive COVID-19 Result

A positive test result means that the virus that causes 

COVID-19 was detected in your sample and it is very likely 

you have COVID-19 and are contagious. Please contact your 

doctor/primary care physician or your local health authority 

immediately and adhere to the local guidelines regarding selfisolation. There is a very small chance that this test can give a 

positive result that is wrong (a false positive result). 
BinaxNOW COVID-19 Ag CARD HOME TEST KIT

17 Check for Negative COVID-19 Result

Find result window and look for a single pink/purple line in window.

•Negative Result: A single pink/purple line on the top half 

where it says “Control.” COVID-19 was not detected.

No Line

Negative

CONTROL

SAMPLE

To increase the chance that the negative result for COVID-19 is accurate, you should:

• Test again in 48 hours if you have symptoms on the first day of testing.

• Test 2 more times at least 48 hours apart if you do not have symptoms on the first day of testing.
BinaxNOW COVID-19 Ag CARD HOME TEST KIT

Negative COVID-19 Result

A negative test result indicates that the virus that causes COVID-19 was not 

detected in your sample. A negative result is presumptive, meaning it is not certain 

that you do not have COVID-19. You may still have COVID-19 and you may still 

be contagious. There is a higher chance of false negative results with antigen tests 

compared to laboratory-based tests such as PCR. If you test negative and continue 

to experience COVID-19-like symptoms, (e.g., fever, cough, and/or shortness of 

breath) you should seek follow up care with your health care provider.

If you or the telehealth proctor disagree on the presence of a faint line and/or the 

presence of a line is uncertain, additional confirmatory testing should be conducted.

It is important that you work with your healthcare provider to help you understand 

the next steps you should take. 
BinaxNOW COVID-19 Ag CARD HOME TEST KIT

18 Check for Invalid Result

If you see any of these, the test is invalid.

Blue control Pink/purple Blue control line AND

No lines seen line only sample line only pink/purple sample line

CONTROL

SAMPLE

An invalid result means this test was unable to determine whether you 

have COVID-19 or not. Re-test with a new swab and new test device. 

Please contact Technical Support at + 1 833-637-1594. 
BinaxNOW COVID-19 Ag CARD HOME TEST KIT

19 Dispose in Trash

BinaxNOWTM

COVID-19 Ag CARD

SAMPLE

CONTROL
BinaxNOW COVID-19 Ag CARD HOME TEST KIT

Reporting Patient Results Using NAVICA

Upon completion of the test and result interpretation, the telehealth proctor will send your test 

results via the NAVICA app. You will be notified by email and on your mobile device that your 

results are ready. You will go to the results screen in NAVICA to obtain your test results.

If your BinaxNOW COVID-19 Ag Card Home Test 

result is Negative, you will receive the following:

If your BinaxNOW COVID-19 Ag Card Home Test 

result is Positive, you will receive the following:
BinaxNOW COVID-19 Ag CARD HOME TEST KIT

Reporting Patient Results Using NAVICA

Upon completion of the test and result interpretation, the telehealth proctor will send your test 

results via the NAVICA app. You will be notified by email and on your mobile device that your 

results are ready. You will go to the results screen in NAVICA to obtain your test results.

If the BinaxNOW COVID-19 Ag Card Home Test 

result is Invalid, you will receive the following:

© 2023 Abbott. All rights reserved.

All trademarks referenced are trademarks of either the 

Abbott group of companies or their respective owners.

IN195101 Rev 6 2023/01
Abbott

BinaxNOW eMed

COVID-19 Ag Card Home Test

Procedure Card

Size: 

16.35 in x 12.21 in

Colors PN: IN195101

Rev: 6

Date of Last Revision: 

6.7 2023/01/30

RGB

For Reference Only

PMS 2995 C

Primary Blue

PMS 303 C

Dark Blue

PMS 224 C

Magenta-Pink
MPV 11.3 FL

PROCTORED BY eMe

d

195-100

1 195-100 2 C° 30 C°

C

OVID-19Ag

Card HOME TEST

D

O

N

OT

OPEN

U

N

TIL INSTR

U

C

T

E

D

T

O

D

O

S

O

HOME TEST

C

OVID

-19Ag

Card

FAST

CERTIFIED RESULTSIN 15 MINUTES

15

DOWNLOADNAVICA APP FOR TEST RESULTS

SCAN QR CODETO BEGIN TEST OR VISIT START.EMED.COM

ID: B-AAB

•Contents:

COVID-19 antigens in nasal swab specimens.A rapid test for the qualitative detection of EN

1 BinaxNOWTM COVID-19 Test Card 

• 1 Nasal Swab• 1 Reagent Bottle•Contents:

1 BinaxNOWTM COVID-19 Test Card 

• 1 Nasal Swab• 1 Reagent Bottle

Store between 35.6-86° F (2-30° C) until use

emergency use of the declaration that circumstances exist justifying the authorization of The emergency use of this product is only authorized for the duration of SARS-CoV-2, not for any other viruses or pathogens; and,This product has been authorized only for the detection of proteins from authorized by FDA under an EUA;This product has not been FDA cleared or approved; but has been 

in vitro diagnostics for detection and/or diagnosis of 

please refer to http://www.fda.gov/covid-testsFor more information on expiration dating for COVID-19 antigen tests, terminated or authorization is revoked sooner.Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is COVID-19 under Section 564(b)(1) of the Federal Food, Drug and emergency use of the declaration that circumstances exist justifying the authorization of The emergency use of this product is only authorized for the duration of SARS-CoV-2, not for any other viruses or pathogens; and,This product has been authorized only for the detection of proteins from authorized by FDA under an EUA;This product has not been FDA cleared or approved; but has been 

in vitro diagnostics for detection and/or diagnosis of 

please refer to http://www.fda.gov/covid-testsFor more information on expiration dating for COVID-19 antigen tests, terminated or authorization is revoked sooner.Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is COVID-19 under Section 564(b)(1) of the Federal Food, Drug and CThis test is more likely to give you a false negative result when you havepurchase additional tests to perform serial (repeat) testing.Determining a negative result requires multiple tests. You may need to 

OVID-19 than a lab-based molecular test. C

This test is more likely to give you a false negative result when you havepurchase additional tests to perform serial (repeat) testing.Determining a negative result requires multiple tests. You may need to 

OVID-19 than a lab-based molecular test. 

PK195100 Rev. 10 2023/01or their respective owners.of either the Abbott group of companies All trademarks referenced are trademarks© 2023 Abbott. All rights reserved.

www.globalpointofcare.eifu.abbottScarborough, Maine 04074 USA10 Southgate RoadAbbott Diagnostics Scarborough, Inc.

195-100

HOME TEST

C

OVID

-19Ag

Card

www.globalpointofcare.eifu.abbott

For use under an Emergency 

Use Authorization only.

For testing with or without symptoms.

This test does NOT determine if 

you had COVID-19 in the past 

or if you have immunity.

Ages 2 and up

Store between 35.6-86° F (2-30° C) until use

For in vitro diagnostic use

•Not Provided:

Smart Phone:* Apple is ios11 or newer, 

 Apple app store from the Google play store or *Required to download the NAVICA app  Android is version 8 or newer

0.72

WEIGHT - oz:

9

f the following:

CODE DATE

NO

TANDARDS:

d with the

drawing.

N ALL FEATURES

COATING REF:

11/18/2021

DATE CREATED:

Y57629A2

57629A

Copy Limits / Print Registration

Non Coated Areas

Bleed Limits

It is the responsibility of the GPI customer to make sure all vital copy (i.e. text, brand logos, etc.) is 1/8” away from knifes and scores for all Offset Folding and Flexo designs; 

1/4" for all Offset Fluted and Gravure.

AS PROVIDED BY SEPARATE WRITTEN AGREEMENT, GPI MAKES NO WARRANTY, EXPRESS, IMPLIED, OR STATUTORY, AS TO THE CONTENTS OF THIS DRAWING.

© 2021 GRAPHIC PACKAGING INTERNATIONAL ALL RIGHTS RESERVED.

Rev.A

LPC - REV TO X940602C - MADE PRODUCTION READY

LPC - REV TO X940602C - MADE PRODUCTION READY

Latest Rev

V:\DESIGNS\PRODUCTION\57000

REVISION HISTORY:

Rev.D

Rev.E

SAP# 7403210 11/22/2021 57629A2 NMM ADDED NEW BLEED AND COATING PATTERN (STAUNTON)

0.056"

0.03"

0.039" 0.078"

OPTIONAL

WAVE PERF

GLUE ASSIST

CUT 50% THRU

EAS TAG ZONE

 (INSIDE OF CARTON)

FPO

PREBREAK 180

PREBREAK 130 MIN.

FOLD #1FOLD #2

2.750

0.500 4.500 0.700 4.500 0.669

0.625

0.669

7.000

0.669

0.625

0.647

0.313

0.375

0.031

15o

15o

0.625R

10.869

9.588

BLEED AREAS - SPECIFIED

NON COATED AREAS - SPECIFIED

0.360 1.750

0.330 1.250

DATE CODE

NO INK/

NO VARNISH

No Varnish

No Varnish

No Varnish

No Varnish

0.125

COPY LIMITS

PMS 2925 C

Primary Blue

PMS 303 C

Dark Blue

C=0, M=9, 

Y=100, K=0

Abbott Yellow

CMYK PN: PK195100 

Rev: 10

Date of Revision: 

10.6 2023/01/10

Abbott 

BinaxNOW eMed 

COVID-19 Ag Card

Home Test

Box, 1 Test

Dieline: 2T7

Dimensions:

4.5 in x 7 in x 0.7 in

Cut Line

Do Not Print

Crease Line

Do Not Print
MPV 11.3 FL

PROCTORED BY eMe

d

195-105

2 195-105 2 C° 30 C°

D

O

N

OT

OPEN

U

N

TIL INSTR

U

C

T

E

D

T

O

D

O

S

O

HOME TEST

FAST

CERTIFIED RESULTSIN 15 MINUTES

15

DOWNLOADNAVICA APP FOR TEST RESULTS

SCAN QR CODETO BEGIN TEST OR VISIT START.EMED.COM

ID: B-AAB

•Contents:

COVID-19 antigens in nasal swab specimens.A rapid test for the qualitative detection of EN

2 BinaxNOWTM COVID-19 Test Cards 

• 2 Nasal Swabs• 2 Reagent Bottles•Contents:

2 BinaxNOWTM COVID-19 Test Cards 

• 2 Nasal Swabs• 2 Reagent Bottles

Store between 35.6-86° F (2-30° C) until use

CThis test is more likely to give you a false negative result when you havepurchase additional tests to perform serial (repeat) testing.Determining a negative result requires multiple tests. You may need to 

OVID-19 than a lab-based molecular test. C

This test is more likely to give you a false negative result when you havepurchase additional tests to perform serial (repeat) testing.Determining a negative result requires multiple tests. You may need to 

OVID-19 than a lab-based molecular test. 

PK195110 Rev. 1 2023/01or their respective owners.of either the Abbott group of companies All trademarks referenced are trademarks© 2023 Abbott. All rights reserved.

www.globalpointofcare.eifu.abbottScarborough, Maine 04074 USA10 Southgate RoadAbbott Diagnostics Scarborough, Inc.

195-105

www.globalpointofcare.eifu.abbott

C

OVID-19Ag

Card HOME TEST

HOME TEST

C

OVID

-19Ag

Card

C

OVID

-19Ag

Card

For use under an Emergency 

Use Authorization only.

For testing with or without symptoms.

This test does NOT determine if 

you had COVID-19 in the past 

or if you have immunity.

emergency use of the declaration that circumstances exist justifying the authorization of The emergency use of this product is only authorized for the duration of SARS-CoV-2, not for any other viruses or pathogens; and,This product has been authorized only for the detection of proteins from authorized by FDA under an EUA;This product has not been FDA cleared or approved; but has been 

in vitro diagnostics for detection and/or diagnosis of 

please refer to http://www.fda.gov/covid-testsFor more information on expiration dating for COVID-19 antigen tests, terminated or authorization is revoked sooner.Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is COVID-19 under Section 564(b)(1) of the Federal Food, Drug and emergency use of the declaration that circumstances exist justifying the authorization of The emergency use of this product is only authorized for the duration of SARS-CoV-2, not for any other viruses or pathogens; and,This product has been authorized only for the detection of proteins from authorized by FDA under an EUA;This product has not been FDA cleared or approved; but has been 

in vitro diagnostics for detection and/or diagnosis of 

please refer to http://www.fda.gov/covid-testsFor more information on expiration dating for COVID-19 antigen tests, terminated or authorization is revoked sooner.Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is COVID-19 under Section 564(b)(1) of the Federal Food, Drug and 

Store between 35.6-86° F (2-30° C) until use

For in vitro diagnostic use

0.72

WEIGHT - oz:

9

f the following:

CODE DATE

NO

TANDARDS:

d with the

drawing.

N ALL FEATURES

COATING REF:

11/18/2021

DATE CREATED:

Y57629A2

57629A

Copy Limits / Print Registration

Non Coated Areas

Bleed Limits

It is the responsibility of the GPI customer to make sure all vital copy (i.e. text, brand logos, etc.) is 1/8” away from knifes and scores for all Offset Folding and Flexo designs; 

1/4" for all Offset Fluted and Gravure.

AS PROVIDED BY SEPARATE WRITTEN AGREEMENT, GPI MAKES NO WARRANTY, EXPRESS, IMPLIED, OR STATUTORY, AS TO THE CONTENTS OF THIS DRAWING.

© 2021 GRAPHIC PACKAGING INTERNATIONAL ALL RIGHTS RESERVED.

Rev.A

LPC - REV TO X940602C - MADE PRODUCTION READY

LPC - REV TO X940602C - MADE PRODUCTION READY

Latest Rev

V:\DESIGNS\PRODUCTION\57000

REVISION HISTORY:

Rev.D

Rev.E

SAP# 7403210 11/22/2021 57629A2 NMM ADDED NEW BLEED AND COATING PATTERN (STAUNTON)

0.056"

0.03"

0.039" 0.078"

OPTIONAL

WAVE PERF

GLUE ASSIST

CUT 50% THRU

EAS TAG ZONE

 (INSIDE OF CARTON)

FPO

PREBREAK 180

PREBREAK 130 MIN.

FOLD #1FOLD #2

2.750

0.500 4.500 0.700 4.500 0.669

0.625

0.669

7.000

0.669

0.625

0.647

0.313

0.375

0.031

15o

15o

0.625R

10.869

9.588

BLEED AREAS - SPECIFIED

NON COATED AREAS - SPECIFIED

0.360 1.750

0.330 1.250

DATE CODE

NO INK/

NO VARNISH

No Varnish

No Varnish

No Varnish

No Varnish

0.125

COPY LIMITS

PMS 2925 C

Primary Blue

PMS 303 C

Dark Blue

C=0, M=9, 

Y=100, K=0

Abbott Yellow

CMYK PN: PK195110 

Rev: 1

Date of Revision: 

1.12 2023/01/10

Abbott 

BinaxNOW eMed 

COVID-19 Ag Card

Home Test

Box, 2 Test

Dieline: 2T7

Dimensions:

4.5 in x 7 in x 0.7 in

Cut Line

Do Not Print

Crease Line

Do Not Print

Ages 2 and up

•Not Provided:

Smart Phone:* Apple is ios11 or newer, 

 Apple app store app from the Google play store or *Required to download the NAVICA  Android is version 8 or newer